BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23760811)

  • 1. Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.
    Pauley JL; Panetta JC; Crews KR; Pei D; Cheng C; McCormick J; Howard SC; Sandlund JT; Jeha S; Ribeiro R; Rubnitz J; Pui CH; Evans WE; Relling MV
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):369-78. PubMed ID: 23760811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.
    Foster JH; Thompson PA; Bernhardt MB; Margolin JF; Hilsenbeck SG; Jo E; Marquez-Do DA; Scheurer ME; Schafer ES
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):349-360. PubMed ID: 30488179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia.
    Wall AM; Gajjar A; Link A; Mahmoud H; Pui CH; Relling MV
    Leukemia; 2000 Feb; 14(2):221-5. PubMed ID: 10673736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country.
    Kapoor G; Sinha R; Abedin S
    Pediatr Blood Cancer; 2012 Sep; 59(3):448-53. PubMed ID: 22271707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Body Fat on Population Pharmacokinetics of High-Dose Methotrexate in Pediatric Patients With Acute Lymphoblastic Leukemia.
    Orgel E; Nabais T; Douglas C; Mittelman SD; Neely M
    J Clin Pharmacol; 2021 Jun; 61(6):755-762. PubMed ID: 33314168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity.
    Foster JH; Bernhardt MB; Thompson PA; Smith EO; Schafer ES
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):72-76. PubMed ID: 27820134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe administration of high-dose methotrexate with minimal drug level monitoring: Experience from a center in north India.
    Dhingra H; Kalra M; Mahajan A
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28394. PubMed ID: 32813334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
    Mangum R; Bernhardt MB; Cheng WS; Schafer ES; Berg SL; Foster JH
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28334. PubMed ID: 32608575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
    Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.
    Sterba J; Dusek L; Demlova R; Valik D
    Clin Chem; 2006 Apr; 52(4):692-700. PubMed ID: 16455868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
    Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
    Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
    Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
    Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
    Tsurusawa M; Gosho M; Mori T; Mitsui T; Sunami S; Kobayashi R; Fukano R; Tanaka F; Fujita N; Inada H; Koh K; Takimoto T; Saito A; Fujimoto J; Nakazawa A; Horibe K;
    Pediatr Blood Cancer; 2015 Feb; 62(2):279-284. PubMed ID: 25359701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
    Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
    Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate in the treatment of adult acute lymphoblastic leukemia.
    Gökbuget N; Hoelzer D
    Ann Hematol; 1996 Apr; 72(4):194-201. PubMed ID: 8624372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.